September 16, 2002—BioShield Technologies, Inc., a biotechnology company focusing on antimicrobial products, has recently received from the U.S. Patent Office an approval extending BioShield’s AM500 antimicrobial, securing the rights to a broader array of applications and formularies.
This new patent approval improves BioShield’s positioning in the coatings industry and various other industries to control the growth of bacteria, mold, mildew and algae for both indoor or outdoor applications. The final patent filing and respective claims are anticipated to be issued as a U.S. Registered Patent within the next few months.
For more information, contact BioShield Technologies.
